Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 21, 2011

C-Reactive protein and neopterin levels in healthy non-obese adults

A. Erkin Bozdemir, Burcu Barutcuoglu, Didem Dereli, Ceyda Kabaroglu, Sara Habif and Oya Bayındır

Abstract

Background: Obesity and increased waist-to-hip ratio, emphasizing the importance of truncal obesity, have been found to correlate positively with increased cardiovascular disease risk and mortality. Owing to the inflammatory nature of atherosclerosis, the aim of our study was to find possible correlations between body mass index and waist-to-hip ratio, and the inflammatory markers C-reactive protein (CRP) and neopterin in healthy lean and overweight adults.

Methods: A total of 49 healthy adults (mean age 42.4±1.8years, 32 females and 17 males) were classified according to their body mass index (BMI) and waist-to-hip ratio values. CRP and neopterin levels were measured.

Results: CRP levels were found to be significantly higher in the group with BMI≥25kg/m2 compared to the group with BMI<25kg/m2 (p=0.014). Subjects with increased waist-to-hip ratio displayed significantly higher serum CRP and neopterin levels (p=0.014 and p=0.033, respectively) compared with the group in which the waist-to-hip ratio was <0.9. A strong positive correlation was found between CRP and BMI in the whole group (r=0.658, p=0.0001).

Conclusions: Grouping overweight subjects according to their waist-to-hip ratio, which is an indicator of truncal obesity, seems to be convenient in studying the inflammatory process in relation to the elevation of adipose tissue. Elevated CRP and neopterin levels may be useful in the assessment of cardiovascular risk in overweight as well as obese subjects.


Corresponding author: A. Erkin Bozdemir, MD, Department of Clinical Biochemistry, Ege University School of Medicine, 35100, Bornova, Izmir, Turkey Phone: +90-232-3904316, Fax: +90-232-3432144, ;

References

1. Jeffreys M, McCarron P, Gunnell D, McEwen J, Smith GD. Body mass index in early and mid-adulthood, and subsequent mortality: a historical cohort study. Int J Obes Relat Metab Disord 2003; 27:1391–7.10.1038/sj.ijo.0802414Search in Google Scholar

2. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003; 254:555–63.10.1111/j.1365-2796.2003.01229.xSearch in Google Scholar

3. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81:555–63.10.1093/ajcn/81.3.555Search in Google Scholar

4. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, et al. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 2004; 27:2033–40.10.2337/diacare.27.8.2033Search in Google Scholar

5. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135–43.10.1161/hc0902.104353Search in Google Scholar

6. Pepys MB, Hirschfield GM. C-Reactive protein: a critical update. J Clin Invest 2003; 111:1805–12.10.1172/JCI200318921Search in Google Scholar

7. Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, Repetti E, et al. Does C-reactive protein identify a subclinical metabolic disease in healthy subjects? Eur J Clin Invest 2005; 35:265–70.10.1111/j.1365-2362.2005.01490.xSearch in Google Scholar

8. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002; 3:175–87.10.2174/1389200024605082Search in Google Scholar

9. Ledochowski M, Murr C, Widner B, Fuchs D. Association between insulin resistance, body mass and neopterin concentrations. Clin Chim Acta 1999; 282:115–23.10.1016/S0009-8981(99)00019-4Search in Google Scholar

10. Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, De Zeeuw D, de Jong PE, PREVEND Study Group. Prevention of Renal and Vascular End-stage Disease. Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med 2000; 38:1107–10.10.1515/CCLM.2000.165Search in Google Scholar PubMed

11. Basdevant A, Cassuto D, Gibault T, Raison J, Guy-Grand B. Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 1994; 18:806–11.Search in Google Scholar

12. Solerte SB, Fioravanti M, Pezza N, Locatelli M, Schifino N, Cerutti N, et al. Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk. Int J Obes Relat Metab Disord 1997; 21:417–23.10.1038/sj.ijo.0800421Search in Google Scholar PubMed

13. Rogowski O, Zeltser D, Shapira I, Burke M, Zakut V, Mardi T, et al. Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones. Biomarkers 2004; 9:85–92.10.1080/13547500410001670303Search in Google Scholar PubMed

14. Kang ES, Kim HJ, Ahn CW, Park CW, Cha BS, Lim SK, et al. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Res Clin Pract 2005; 69:151–9.10.1016/j.diabres.2004.11.014Search in Google Scholar PubMed

15. Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A, et al. Determination of neopterin in serum and urine. Clin Chem 1987; 33:62–6.10.1093/clinchem/33.1.62Search in Google Scholar

16. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99:855–60.10.1161/01.CIR.99.7.855Search in Google Scholar

17. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C-Reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002; 51:1596–600.10.2337/diabetes.51.5.1596Search in Google Scholar PubMed

18. Ridker PM, Buring JE, Cook NR, Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003; 107:391–7.10.1161/01.CIR.0000055014.62083.05Search in Google Scholar PubMed

19. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731–3.10.1161/01.CIR.98.8.731Search in Google Scholar

20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97:425–8.10.1161/01.CIR.97.5.425Search in Google Scholar

21. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99:237–42.10.1161/01.CIR.99.2.237Search in Google Scholar PubMed

22. Volanakis JE. Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982; 389:235–50.10.1111/j.1749-6632.1982.tb22140.xSearch in Google Scholar PubMed

23. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91:1351–7.10.1172/JCI116336Search in Google Scholar PubMed PubMed Central

24. Zwaka TP, Hombach V, Torzewski J. C-Reactive protein-mediated low-density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001; 103:1194–7.10.1161/01.CIR.103.9.1194Search in Google Scholar

25. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102:1000–6.10.1161/01.CIR.102.9.1000Search in Google Scholar PubMed

26. Tracy RP. Is visceral adiposity the “enemy within”? Arterioscler Thromb Vasc Biol 2001; 21:881–3.10.1161/01.ATV.21.6.881Search in Google Scholar

27. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95:2111–9.10.1172/JCI117899Search in Google Scholar PubMed PubMed Central

28. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265:621–36.10.1042/bj2650621Search in Google Scholar PubMed PubMed Central

29. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105:804–9.10.1161/hc0702.104279Search in Google Scholar PubMed

30. Millner MM, Franthal W, Thalhammer GH, Berghold A, Aigner RM, Fuger GF, et al. Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 1998; 44:161–7.10.1093/clinchem/44.1.161Search in Google Scholar

31. Rudzite V, Silava A, Kalnins U, Erglis A, Jäger M, Trushinskis K, et al. Association between increased serum neopterin and homocysteine concentrations as well as pyridoxal-5-phosphate deficiency in patients with coronary heart disease. Pteridines 2001; 12:130–4.10.1515/pteridines.2001.12.3.130Search in Google Scholar

32. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995; 346:1080–4.10.1016/S0140-6736(95)91747-0Search in Google Scholar

33. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G. Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Intern Med 2001; 250:502–7.10.1046/j.1365-2796.2001.00914.xSearch in Google Scholar PubMed

34. Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 1998; 41:694–700.10.1007/s001250050970Search in Google Scholar PubMed

35. Andersson B, Wikstrand J, Ljung T, Bjork S, Wennmalm A, Bjorntorp P. Urinary albumin excretion and heart rate variability in obese women. Int J Obes Relat Metab Disord 1998; 22:399–405.10.1038/sj.ijo.0800600Search in Google Scholar PubMed

36. Cikim AS, Ozbey N, Orhan Y. Relationship between cardiovascular risk indicators and types of obesity in overweight and obese women. J Int Med Res 2004; 32:268–73.10.1177/147323000403200306Search in Google Scholar PubMed

Received: 2005-10-6
Accepted: 2005-12-1
Published Online: 2011-9-21
Published in Print: 2006-3-1

©2006 by Walter de Gruyter Berlin New York

Scroll Up Arrow